David Rescott

Stock Analyst at Baird

(1.37)
# 1364
Out of 5,291 analysts
62
Total ratings
54.55%
Success rate
11.51%
Average return
10 Stocks
Name Action Price Target Current % Upside Ratings Updated
Intuitive Surgical
Maintains: Outperform
707 600
491.6 22.05% 2 Mar 18, 2025
Penumbra
Maintains: Strong Buy
285 325
266.95 21.75% 26 Feb 19, 2025
Medtronic
Maintains: Neutral
90 91
87.61 3.87% 4 Feb 19, 2025
Inari Medical
Downgrades: Neutral
81 80
n/a n/a 4 Jan 7, 2025
Merit Medical System...
Maintains: Outperform
107 109
103.96 4.85% 2 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
66 72
39.12 84.05% 3 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
73 68
70.9 -4.09% 3 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
90 91
99.27 -8.33% 4 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
73 71
n/a n/a 8 Jan 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
25 26
14.03 85.32% 6 Dec 22, 2023